BKV Corp (ticker: BKV) filed a Form 4 on 20 Jun 2025 disclosing an equity award to non-employee director Sunit S. Patel. On 19 Jun 2025 Mr. Patel received 5,761 restricted stock units (RSUs) at a grant price of $0 as part of the company’s standard non-employee director compensation program. Each RSU converts into one share of BKV common stock when vested.
The RSUs vest in full on the day prior to the 2026 annual shareholder meeting, providing roughly a one-year service and performance horizon. Following the grant, Mr. Patel’s total beneficial ownership increased to 55,761 shares, all held directly. No derivative securities or sales were reported, and the filing makes no reference to a Rule 10b5-1 trading plan.
From an investor perspective, the transaction is routine board compensation with immaterial dilution and no immediate cash impact on the company. It modestly aligns director incentives with shareholder value creation but does not signal a change in strategic outlook or financial condition. The filing satisfies Section 16 reporting requirements and carries no additional earnings data or operational disclosures.
BKV Corporation (ticker: BKV) filed a Form 4 disclosing an insider equity grant to director Charles C. Miller III. On 19 June 2025, Mr. Miller was awarded 5,761 restricted stock units (RSUs) under the company’s non-employee director compensation plan at a cost basis of $0.00. Each RSU converts into one share of common stock and will vest the day before BKV’s 2026 annual shareholder meeting.
Following this grant, the filing shows Miller’s updated beneficial ownership position at 5,761 shares held directly (the newly granted RSUs) and 87,500 shares held indirectly through the Miller/Allen Living Trust dated 8 January 2020.
No derivative securities were reported, and the transaction code "A" confirms the acquisition was an award rather than an open-market purchase. The filing was signed on 20 June 2025 by attorney-in-fact Kathleen Lenox.
For investors, this is a routine director equity grant designed to align board incentives with shareholder interests. The size of the award is modest relative to BKV’s total shares outstanding and does not, by itself, signal a material change in the company’s outlook or capital structure.